Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Novavax applies for FDA nod for its updated COVID vaccine
Center for Infectious Disease Research and Policy· 3 days agoThe company said it will have the vaccine ready to distribute in mid July as prefilled syringes, pending approval and recommendations.
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 17 hours agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 6 days agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 6 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared ...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 6 days agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Jim Cramer Says He's 'Going To Have To Wait' On SoFi, But Recommends This 'Great Little Industrial...
Benzinga· 4 days agoOn CNBC's “Mad Money Lightning Round,” Jim Cramer said he still can't recommend Twilio TWLO. On June...
FDA recommends COVID jab manufacturers update formulas to combat new strain
BizPac Review· 6 days agoA new strain of COVID has prompted recommendations for vaccine companies to update their formulas in anticipation of cases in the fall. The U.S. Food and Drug Administration ...
Texas Biomed expanding animal research complex with $20 million building
San Antonio Express-News· 1 day agoThe 18,440-square-foot building will house Texas Biomed’s Animal Health Center, the next phase of...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 7 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....